Leap Venture Studio Opens Applications for a Record-Chasing Cohort 11
Leap Venture Studio is accepting applications for Cohort 11 through October 18th, returning to a spring start after a record 300-plus applications for Cohort 10. The program offers portfolio startups mentorship, capital, and access to investors from Mars Petcare, TAW Ventures, and Michelson Found Animals, with this cycle prioritizing pet healthspan, feline-first care, senior pets, dental health, and allergy solutions.
A pet-care accelerator that pulled in more than 300 applications from over 40 countries last cycle is opening its doors again, on a new calendar. Leap Venture Studio is now accepting submissions for its 11th Studio program through October 18th, with the cohort shifting back to a spring start.
Leap Venture Studio reopens for an eleventh pet-startup cohort
Leap Venture Studio, the pet-care accelerator backed by Mars Petcare, TAW Ventures, and Michelson Found Animals, opened applications for Cohort 11 on September 14th. The window closes October 18th at 11:59 PM PT, and selected startups begin a 12-week hybrid program on March 30th, 2027.
The program pairs each portfolio company with mentors, entrepreneurs-in-residence, and operational and brand support, plus access to the three partners' networks of investors. One Impact Seat is again reserved for a startup measured on ecosystem impact rather than growth, open to nonprofits and for-profits alike. That application runs separately from the main cohort track.
For Cohort 11, the accelerator says it will prioritize startups working on pet healthspan and science-backed wellness, with particular interest in feline-first care, senior pets, dental health, and allergy treatment.
The spring move follows a record applicant pool
We covered Leap Venture Studio's Cohort 10 selections after that cycle drew the same 300-plus applications from 40-plus countries now cited as the reason for this schedule change. That pool produced six portfolio companies and brought Leap's total since 2018 to 63 startups across 17 markets.
The release doesn't say how many companies will make up Cohort 11. Leap is keeping the per-portfolio-company allocation at $200,000, the same figure Cohort 10 carried. Which startups claim those seats won't be clear until the program announces its picks.
Two information sessions precede the October 18th deadline
Leap Venture Studio is running two virtual info sessions before applications close: one on September 23rd (register here) at 8:00 AM PT, and one on October 7th (register here) at 1:00 PM PT. Startups can apply for Cohort 11 or apply for the Impact Seat directly.
Other News
More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.
After 13 Years Photographing Dogs, The Dogist Launches Its First Product
Elias Weiss Friedman's picky-eater dog, Elsa, inspired his first product: Vitality, a $35 antioxidant chew developed with a board-certified veterinary nutritionist. Preorders open now ahead of a September 22nd release on The Dogist Company's site and TikTok Shop.
$250M Duffield Pledge Raises the Stakes on Vet Care Access
The Dave & Cheryl Duffield Foundation is committing $250 million over five years to expand nonprofit veterinary care, an initiative it calls the Duffield Big Bet for Pets. The pledge follows PetSmart Charities' $100 million commitment in 2023, pushing dedicated access-to-care philanthropy past $350 million in three years. For operators, the money increasingly funds nonprofit clinic capacity, not just family subsidies.
Loyal's Third Longevity Drug Clears the FDA's First Efficacy Bar
Loyal's LOY-003, a large-breed longevity drug targeting the growth hormone/IGF-1 pathway, has cleared the FDA's Reasonable Expectation of Effectiveness bar, the company's third such acceptance. The milestone de-risks Loyal's broader platform even as its furthest-along drug, LOY-002, still awaits a manufacturing review before conditional approval.